Clinical Trial

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

Name: Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo — clinical trial record (NCT07437560)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MTII-VIT

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This example interventional study record describes a randomized Phase 2 clinical trial evaluating investigational Melanotan II (MT-II) as an adjunct to standard NB-UVB phototherapy for repigmentation in adults with stable nonsegmental vitiligo.

Trial Details

NCT Number	NCT07437560
Lead Sponsor	Hudson Biotech
Conditions	NonSegmental Vitiligo, Nonsegmental Vitiligo (Stable)
Enrollment	60 participants
Start Date	2026-02-02
Primary Completion	2027-02-14 (estimated)
Study Completion	2028-02-17 (estimated)
Updated on ClinicalTrials.gov	2026-02-27